|
1
|
Warnalulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar
|
|
2
|
Hernández-Guerrero JC, Jacinto-Alemán LF,
Jiménez-Farfán MD, Macario-Hernández A, Hernández-Flores F and
Alcántara-Vázquez A: Prevalence trends of oral squamous cell
carcinoma. Mexico City’s General Hospital experience. Med Oral
Patol Oral Cir Bucal. 18:e306–e311. 2013.PubMed/NCBI
|
|
3
|
Bagan J, Sarrion G and Jimenez Y: Oral
cancer: clinical features. Oral Oncol. 46:414–417. 2010. View Article : Google Scholar
|
|
4
|
Shah JP and Gil Z: Current concepts in
management of oral cancer-surgery. Oral Oncol. 45:394–401. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kurita H, Nakanishi Y, Nishizawa R, Xiao
T, Kamata T, et al: Impact of different surgical margin conditions
on local recurrence of oral squamous cell carcinoma. Oral Oncol.
46:814–817. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pérez I, Varona A, Blanco L, Gil J,
Santaolalla F, et al: Increased APN/CD13 and acid aminopeptidase
activities in head and neck squamous cell carcinoma. Head Neck.
31:1335–1340. 2009.PubMed/NCBI
|
|
7
|
Yi R and Fuchs E: MicroRNAs and their
roles in mammalian stem cells. J Cell Sci. 124:1775–1783. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Valastyan S, Chang A, Benaich N, Reinhardt
F and Weinberg RA: Activation of miR-31 function in
already-established metastases elicits metastatic regression. Genes
Dev. 25:646–659. 2011. View Article : Google Scholar
|
|
9
|
Hou J, Lin L, Zhou W, Wang Z, Ding G, et
al: Identification of miRNomes in human liver and hepatocellular
carcinoma reveals miR-199a/b-3p as therapeutic target for
hepatocellular carcinoma. Cancer Cell. 19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu J, Guo H, Li H, Liu Y, Liu J, et al:
MiR-145 regulates epithelial to mesenchymal transition of breast
cancer cells by targeting Oct4. PLoS One. 7:e459652012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hammond SM: MicroRNAs as tumor
suppressors. Nat Genet. 39:582–583. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sachdeva M and Mo YY: MicroRNA-145
suppresses cell invasion and metastasis by directly targeting mucin
1. Cancer Res. 70:378–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cho WC, Chow AS and Au JS: Restoration of
tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung
adenocarcinoma patients with epidermal growth factor receptor
mutation. Eur J Cancer. 45:2197–2206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo L, Liu Y, Bai Y, Sun Y, Xiao F and Guo
Y: Gene expression profiling of drug-resistant small cell lung
cancer cells by combining microRNA and cDNA expression analysis.
Eur J Cancer. 46:1692–1702. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu Y, Chen W, Zhang Y, Hamburger AW, Pan H
and Zhang Z: Suppression of salivary adenoid cystic carcinoma
growth and metastasis by ErbB3 binding protein Ebp1 gene transfer.
Int J Cancer. 120:1909–1913. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cho WC: MicroRNAs: potential biomarkers
for cancer diagnosis, prognosis and targets for therapy. Int J
Biochem Cell Biol. 42:1273–1281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chiyomaru T, Enokida H, Tatarano S,
Kawahara K, Uchida Y, et al: miR-145 and miR-133a function as
tumour suppressors and directly regulate FSCN1 expression in
bladder cancer. Br J Cancer. 102:883–891. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spizzo R, Nicoloso MS, Lupini L, Lu Y,
Fogarty J, et al: miR-145 participates with Tp53 in a
death-promoting regulatory loop and targets estrogen receptor-alpha
in human breast cancer cells. Cell Death Differ. 17:246–254. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gregersen LH, Jacobsen AB, Frankel LB, Wen
J, Krogh A and Lund AH: MicroRNA-145 targets YES and STAT1 in colon
cancer cells. PLoS One. 5:e88362010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kano M, Seki N, Kikkawa N, Fujimura L,
Hoshino I, et al: MiR-145, miR-133a and miR-133b: Tumor suppressive
miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J
Cancer. 127:2804–2814. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takagi T, Iio A, Nakagawa Y, Naoe T,
Tanigawa N and Akao Y: Decreased expression of microRNA-143 and
-145 in human gastric cancers. Oncology. 77:12–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu T, Wang XY, Gong RG, Li A, Yang S, et
al: The expression profile of microRNAs in a model of
7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in
Syrian hamster. J Exp Clin Cancer Res. 28:642009.PubMed/NCBI
|
|
23
|
Sachdeva M, Zhu S, Wu F, Wu H, Walia V, et
al: p53 represses c-Myc through induction of the tumor suppressor
miR-145. Proc Natl Acad Sci USA. 106:3207–3212. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen X, Gong J, Zeng H, Chen N, Huang R,
et al: MicroRNA-145 targets BNIP3 and suppresses prostate cancer
progression. Cancer Res. 70:2728–2738. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Drebber U, Lay M, Wedemeyer I, Vallböhmer
D, Bollschweiler E, et al: Altered levels of the onco-microRNA 21
and the tumor-supressor microRNAs 143 and 145 in advanced rectal
cancer indicate successful neoadjuvant chemoradiotherapy. Int J
Oncol. 39:409–415. 2011.
|
|
26
|
Chung YW, Bae HS, Song JY, Lee JK, Lee NW,
et al: Detection of microRNA as novel biomarkers of epithelial
ovarian cancer from the serum of ovarian cancer patient. Int J
Gynecol Cancer. 23:673–679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi B, Sepp-Lorenzino L, Prisco M, Linsley
P, deAngelis T and Baserga R: Micro RNA-145 targets in insulin
receptor substrate-1 and inhibits the growth of colon cancer cells.
J Biol Chem. 282:32582–32590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zaman MS, Chen Y, Deng G, Shahryari V, Suh
SO, et al: The functional significance of microRNA-145 in prostate
cancer. Br J Cancer. 103:256–264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang S, Bian C, Yang Z, Bo Y, Li J, et al:
miR-145 inhibits breast cancer cell growth through RTKN. Int J
Oncol. 34:1461–1466. 2009.PubMed/NCBI
|
|
30
|
Xu N, Papagiannakopoulos T, Pan G, Thomson
JA and Kosik KS: MicroRNA-145 regulates OCT4, SOX2, and KLF4 and
represses pluripotency in human embryonic stem cells. Cell.
137:647–658. 2009. View Article : Google Scholar : PubMed/NCBI
|
